-
-
-
-
-
-
-
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
-
-
-
-
-
-
-
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
-
-
-
-
-
-
-
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
-
-
-
-
-
-
-
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
-
-
-
-
-
-
-
QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021
-
-
-
-
-
-
-
Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests
-
-
-
-
-
-
-
QIAGEN Reports Results for Third Quarter and First Nine Months of 2017
-
102,016 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

